Research Interest

Fymat’s current research interests lie at the interface between science and medicine, particularly nanomedicine, nanobiotechnology, cancer/oncology, molecular/personal/precision medicine, human genetics/epigenetics/ecogenetics, neurodegenerative diseases, pharmacology and pharmacogenomics. His most recent publications  deal with nanotechnology and cancer, nanochemotherapy, nanoneurology, natural and synthetic immunotherapy, drug delivery across the brain protective barriers, and neurodegenerative disorders (including dementias, epilepsy, Parkinson's and Alzheimer's disease).

Subscribe To Our Newsletter For More Event Updates